Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.65 |
| ▸ | CES2 | O00748 | 3/20 | 0.65 |
| ▸ | CES1 | P23141 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.56 |
| ▸ | PKM | P14618 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | ATM | Q13315 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinic Acid SCHEMBL27979899 | 0.86 | KMT2A (0.70) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| P-Xylene SCHEMBL14721484 | 0.81 | ALDH1A1 (0.67) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| P-Xylene SCHEMBL27538150 | 0.81 | ALDH1A1 (0.67) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| 4-Methylbenzoic Acid SCHEMBL7261856 | 0.80 | ALDH1A1 (0.94) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL52200 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL167254 | 0.79 | CES2 (1.00) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL822185 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| 4-Methylbenzoic Acid SCHEMBL30415250 | 0.78 | ALDH1A1 (0.59) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL7218812 | 0.78 | CES2 (0.75) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| Terephthalic Acid SCHEMBL526449 | 0.77 | ALDH1A1 (1.00) | ALDH1A1CES2CES1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 861 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9884882-B2 | Method for producing thiolane skeleton-type glycoconjugate, and thiolane skeleton-type glycoconjugate | FUJIFILM CORPORATION (JP) | 2018-02-06 | — | — | US | claimed |
| EP-3109245-B1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORP (JP) | 2018-01-03 | — | — | EP | claimed |
| EP-3109245-A1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM Corporation (JP) | 2016-12-28 | — | — | EP | claimed |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORPORATION (JP) | 2016-12-08 | — | — | US | claimed |
| US-20150322094-A1 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2015-11-12 | — | — | US | claimed |
| EP-2892343-A1 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | Bayer CropScience AG (DE) | 2015-07-15 | — | — | EP | claimed |
| WO-2014037349-A1 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2014-03-13 | — | — | WO | claimed |
| US-20110184173-A1 | Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity | THE KITASATO INSTITUTE (JP) | 2011-07-28 | — | — | US | claimed |
| EP-2228376-A1 | PYRIPYROPENE DERIVATIVE HAVING ACAT2-INHIBITING ACTIVITY | The Kitasato Institute (JP) | 2010-09-15 | — | — | EP | claimed |
| US-6933296-B2 | Compounds effective as β2-adrenoreceptor agonists as well as PDE4-inhibitors | ALTANA PHARMA B.V. (NL) | 2005-08-23 | — | — | US | claimed |
| US-4619992-A | IMPROVED COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-28 | — | — | US | claimed |
| EP-0157420-A2 | Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) | 1985-10-09 | — | — | EP | claimed |
| US-4496480-A | Isothiazolazo dyes having coupling components which are free from unsaturated aliphatic radicals | BASF AKTIENGESELLSCHAFT (DE) | 1985-01-29 | — | — | US | claimed |
| US-4416879-A | CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-11-22 | — | — | US | claimed |
| US-4385182-A | SENSITIZERS OR PHOTOINITIATORS | CIBA-GEIGY CORPORATION (US) | 1983-05-24 | — | — | US | claimed |
| US-4188388-A | Phenoxy pyridazinones and anorexigenic use thereof | ALBERT ROLLAND S.A. (FR) | 1980-02-12 | — | — | US | claimed |
| US-4161598-A | ANALGESICS, NARCOTIC ANTAGONISTS | STERLING DRUG INC. (US) | 1979-07-17 | — | — | US | claimed |
| US-4096143-A | Process for producing phthalazinone and derivatives of the same | FUJI PHOTO FILM CO., LTD. (JA) | 1978-06-20 | — | — | US | claimed |
| US-4089865-A | Certain thiazole compounds | SYNTEX (U.S.A.) INC. (US) | 1978-05-16 | — | — | US | claimed |
| US-4086423-A | CEPHALOSPORINS, CYCLOADDITION OF GLYCINE DERIVATIVE TO THIAZINE COMPOUND | MERCK & CO., INC. (US) | 1978-04-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322094-A1 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | CAT, HSF1, HPD | ALDH1A1 24/4885CES2 1061/4885CES1 1114/4885 |
| US-20110184173-A1 | Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity | ACAT2, ACAT1, AGPAT2 | ALDH1A1 1202/4885CES2 953/4885CES1 144/4885 |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | ST6GAL1, FUT6, FUT5 | ALDH1A1 423/4885CES2 699/4885CES1 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.